NCT04328714 2026-02-13
Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease
Emory University
Phase 1 Terminated
Clinical Trials
23 trialsNCT03747484 2025-03-06
Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
Fred Hutchinson Cancer Center
Phase 1/2 Terminated
NCT03063632 2023-10-25
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT03112590 2023-04-19
Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Completed
NCT00428272 2019-12-17
HGS-ETR2 to Treat Children With Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT02614456 2019-11-29
Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors
Fox Chase Cancer Center
Phase 1 Completed
NCT01957709 2019-07-10
Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
Fred Hutchinson Cancer Center
Phase EARLY_PHASE1 Terminated
NCT00003414 2015-07-20
Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 3 Completed
NCT00006113 2014-05-22
Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
University of Southern California
Phase 2 Terminated
NCT00024271 2014-01-06
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00070187 2013-10-17
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
Children's Oncology Group
Phase 2/3 Completed
NCT00002475 2013-07-10
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00059878 2013-06-19
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
National Cancer Institute (NCI)
Phase 2 Completed
NCT00004016 2013-06-06
Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
University of Rochester
Phase 1 Completed
NCT00008203 2013-02-04
Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002796 2013-02-01
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer
National Cancer Institute (NCI)
Phase 1/2 Terminated
NCT00004032 2013-01-23
Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00002761 2012-11-19
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Columbia University
Phase 1/2 Withdrawn
NCT00501644 2012-08-07
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00786643 2012-03-01
GFL
Accelerated Community Oncology Research Network
Phase 2 Completed
NCT00616720 2011-05-16
Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
Mayo Clinic
Phase 2 Completed
NCT00002505 2011-05-12
Tumor Cell Vaccine in Treating Patients With Advanced Cancer
Hoag Memorial Hospital Presbyterian
Phase 2 Completed
NCT00001296 2008-03-04
A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma
National Institutes of Health Clinical Center (CC)
Phase 3 Completed